Emine ÇÖLGEÇEN, Çiğdem KADER, Yılmaz ULAŞ, Pınar ÖZTÜRK, Mehmet BALCI, Öznur KÜÇÜK

Pityriasis rosea: a natural history of pediatric cases in the Central Anatolia Region of Turkey

Background/aim: This study aimed to evaluate the demographic, clinical, and epidemiological features of pityriasis rosea (PR) in a cohort of 46 children in Yozgat, a city in the Central Anatolia Region of Turkey. Materials and methods: Forty-six children with PR were monitored at regular intervals (1, 2, 4, and 12 weeks) for 3 months from the time of diagnosis. A complete evaluation of the patient was performed at each visit. Results: The average age of patients at time of diagnosis was 12 ± 3.9 years. Cases were most common in the winter (rainy, snowy months; n = 14, 31%). Fifteen patients had a medical history significant for the presence of upper respiratory tract infection, while skin PR manifestations were preceded by drug intake in a second group of 15 patients. The presence of a herald patch was observed in 78.3% of patients, most frequently on the trunk (n = 23). Pruritus occurred in 75% of patients. Median PR duration was 3 weeks (range: 1 20 weeks). Conclusion: The course of PR is similar in Turkish children and adults. The high prevalence of pruritus in children with PR in Turkey was also significant. Further evaluation of this finding comparing adults and children is now required.

PDF

___

1. Gündüz O, Ersoy-Evans S, Karaduman A. Childhood pityriasis rosea. Pediatr Dermatol 2009; 26: 750-751.
2. Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct is the classic description? Arch Pediatr Adolesc Med 2007; 161: 503-506.
3. Browning JC. An update on pityriasis rosea and other similar childhood exanthems. Curr Opin Pediatr 2009; 21: 481-485.
4. Stulberg DL, Wolfrey J. Pityriasis rosea. Am Fam Physician 2004; 69: 87-91.
5. Chuh AA. Diagnostic criteria for pityriasis rosea: a prospective case control study for assessment of validity. J Eur Acad Dermatol Venereol 2003; 17: 101-103.
6. Gül U, Cakmak SK, Gönül M, Kiliç A, Bilgili S. Pediatric skin disorders encountered in a dermatology outpatient clinic in Turkey. Pediatr Dermatol 2008; 25: 277-278.
7. Chuang TY, Perry HO, Ilstrup DM, Kurland LT. Recent upper respiratory tract infection and pityriasis rosea: a case-control study of 249 matched pairs. Br J Dermatol 1983; 108: 587-591.
8. Canpolat Kirac B, Adisen E, Bozdayi G, Yucel A, Fidan I, Aksakal N, Gurer MA. The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea. J Eur Acad Dermatol Venereol 2009; 23: 16-21.
9. Drago F, Malaguti F, Ranieri E, Losi E, Rebora A. Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study. J Cutan Pathol 2002; 29: 359-361.
10. Chuh AA, Chan HH. Prospective case-control study of chlamydia, legionella and mycoplasma infections in patients with pityriasis rosea. Eur J Dermatol 2002; 12: 170-173.
11. Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpesviruses: facts and controversies. Clin Dermatol 2010; 28: 497-501.
12. Rajpara SN, Ormerod AD, Gallaway L. Adalimumab-induced pityriasis rosea. J Eur Acad Dermatol Venereol 2007; 21: 1294- 1296.
13. Polat M, Yildirim Y, Makara A. Palmar herald patch in pityriasis rosea. Australas J Dermatol 2012; 53: 64-65.
14. Harman M, Aytekin S, Akdeniz S, Inalöz HS. An epidemiological study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol 1998; 14: 495-497.
15. González LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol 2005; 44: 757-764.
16. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 1982; 7: 80-89.
17. Blauvelt A. Pityriasis rosea. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatricks Dermatology in General Medicine. 7th ed. New York, NY, USA: McGraw-Hill; 2008. pp. 362-366.